From having developed over 80 large molecule dose forms, Patheon has extensive experience ranging from early formulation development through to product commercialization. Product development is supported by robust site infrastructure including Bioanalytical laboratories (including cell-based assays) and storage of refrigerated and frozen drug products (-20°C and -70°C). Liquid and lyophilized products are effectively managed using minimal amounts of API.